News

25 August 2021
Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution in Canada, to perform a Left Atrial Appendage Closure (LAAC) procedure.
Press Release
03 August 2021
The company is establishing a manufacturing plant in La Lima Free Zone, in Cartago, where it will manufacture cardiovascular products to serve global markets.
Press Release
29 July 2021
Baylis Medical announced today the first clinical use of the VersaCross® Large Access Solution.
Press Release
05 May 2021
Baylis Medical is proud to announce that it is a Gold Standard Winner of the Canada’s Best Managed Companies award.
Press Release
19 January 2021
Baylis Medical announced today the launch and first clinical case in Europe of the JLL 2-French electrophysiology microcatheter.
Press Release
01 December 2020
A recent publication demonstrated procedural efficiency for MitraClip™ transcatheter mitral valve repair (TMVR) with use of the VersaCross® RF Transseptal Solution.
Press Release

Media Contact

media@baylismedical.com